Medinet Co., Ltd. operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medinet Co., Ltd. with three other
companies in this sector in Japan:
sales of 1.80 billion Japanese Yen [US$16.07 million]
of which 55%
was Cell Therapy Support Business),
Trans Genic Inc
(2.29 billion Japanese Yen [US$20.43 million]
of which 48%
was CRO Business), and
Symbio Pharmaceuticals Ltd
(2.37 billion Japanese Yen [US$21.12 million]
of which 100%
was Auxiliary Business).
Medinet Co., Ltd. reported sales of ¥1.91 billion (US$17.03 million)
September of 2016.
increase of 14.0%
versus 2015, when the company's sales were ¥1.67 billion.
Sales of Cell Therapy Products Business saw an increase
that was more than double the company's growth rate: sales were up
290.0% in 2016, from
¥8.36 million to ¥32.60 million.